Treatment of Childhood Acute Myeloid Leukemia in Bulgaria
Background: During the last four decades the prognosis of childhood acute myeloid leukemia (AML) has been substantially improved due to an increase in complete remission (CR) rates, event-free survival (EFS) and reduced early mortality. The relapsed AML still remains a therapeutic challenge.
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2018-06-01
|
Series: | Folia Medica |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/folmed.2017.60.issue-2/folmed-2017-0090/folmed-2017-0090.xml?format=INT |